Shah, G., Zambrano, K., Rubio, A. A., Abbasi, A., Zabakhidze, T., Solangi, A., Mohapatra, S., Abbasi, M., Kanwal, R., Kumar, M., Johnson, A. D., Solangi, Z. (2026). Survival outcomes with first-line platinum–etoposide plus durvalumab versus platinum–etoposide alone in extensive-stage small cell lung cancer with metastatic disease including brain metastases: A real world analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e20138